*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Please contact James Dahlman with questions.
Summary Sentence: Omar Abudayyeh & Jonathan Gootenberg - McGovern Fellows, Massachusetts Institute of Technology
Full Summary: Omar Abudayyeh & Jonathan Gootenberg - McGovern Fellows, Massachusetts Institute of Technology
Gene Editing / Therapy Seminar Series 2021Omar Abudayyeh
Fellow, McGovern Institute
Massachusetts Institute of Technology
Jonathan Gootenberg
Fellow, McGovern Institute
Massachusetts Institute of Technology
Join this virtual event via BlueJeans
ABUDAYYEH BIOGRAPHY
Omar Abudayyeh is a McGovern Institute Fellow at the Massachusetts Institute of Technology where he conducts independent research on investigating novel bacterial defense systems for genome editing and gene delivery properties. He previously was at Harvard Medical School and the Harvard-MIT Health Sciences and Technology program as an MD/PhD student. He completed his doctoral work in Feng Zhang’s lab at the Broad Institute of MIT and Harvard, where his research centered on novel CRISPR enzymes for applications in genome editing, therapeutics, and diagnostics. In recognition of his technology developments, Dr. Abudayyeh was recognized as 2018 Forbes 30 under 30 in Science and Health Care and Business Insider 30 under 30. Dr. Abudayyeh graduated from MIT in 2012 with a B.S. in mechanical engineering and biological engineering, where he was a Henry Ford II Scholar and a Barry M. Goldwater Scholar.
GOOTENBERG BIOGRAPHY
Jonathan Gootenberg earned his bachelor’s degree in mathematics and biological engineering at MIT. He received his PhD in Systems Biology from Harvard University, during which he conducted research with Aviv Regev and Feng Zhang at the McGovern Institute and Broad Institute of MIT and Harvard. During his PhD, Gootenberg focused on the development of molecular technologies for treating and sensing disease states, crossing disciplines by utilizing novel computational techniques, microbiology, biochemistry, and molecular biology to uncover new CRISPR tools, including Cas12 and Cas13. He and his co-authors developed Cas13 into a toolbox with uses in fundamental research, therapeutics, and diagnostics. He is one of the first members of the McGovern Institute Fellows program, which supports the transition to independent research for exceptional recent PhD graduates, and has received multiple awards, including Forbes 30 Under 30 and Business Insider 30 and Under.
The Gene Editing / Gene Therapy Seminar Series features leading academic, translational, and investor speakers in e-talks through the summer and fall.
